Related Experiment Videos

Purine uptake by azaguanine-resistant Chinese hamster cells

Insights

Chinese hamster ovary cells resistant to azaguanine exhibit two distinct mechanisms. Some lack hypoxanthine-guanine phosphoribosyltransferase (HPRT), while others show reduced purine uptake and incorporation due to a modified HPRT.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Genetics

Background:

  • Azaguanine is a purine analog used to select for drug-resistant cells.
  • Hypoxanthine-guanine phosphoribosyltransferase (HPRT) is a key enzyme in purine salvage pathways.
  • Chinese hamster ovary (CHO) cells are a common model system in toxicology and genetics.

Purpose of the Study:

  • To investigate the mechanisms of azaguanine resistance in CHO cells.
  • To differentiate between HPRT-deficient and other forms of resistance.
  • To understand the role of purine uptake and incorporation in drug resistance.

Main Methods:

  • Culturing CHO cell lines with varying azaguanine resistance levels.
  • Measuring the uptake of radiolabeled hypoxanthine and azaguanine.
  • Assessing the incorporation of these purines into trichloroacetic acid-insoluble cellular components (DNA and RNA).

Main Results:

  • Two classes of azaguanine-resistant CHO cells were identified.
  • Class 1: Cells deficient in HPRT showed no uptake of exogenous hypoxanthine or azaguanine.
  • Class 2: Cells with near-wild-type HPRT levels exhibited reduced purine uptake and incorporation into nucleic acids.

Conclusions:

  • Azaguanine resistance in CHO cells can arise from HPRT deficiency or altered purine metabolism.
  • A modified HPRT enzyme, functional for hypoxanthine but not azaguanine, may underlie the second resistance mechanism.
  • Reduced incorporation of azaguanine into DNA and RNA is a key feature of this modified HPRT-mediated resistance.

Related Concept Videos